Lab study finds AstraZeneca drug neutralizes Omicron

Lab study finds AstraZeneca drug neutralizes Omicron


AstraZeneca said its antibody-based cocktail to prevent and treat COVID retained neutralizing activity against Omicron coronavirus variants, including the highly contagious BA.2 sub-variant, in an independent lab study.

News #Reuters #Omicron #Vaccine #COVID


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram: